Sage Therapeutics Inc.
13F holders, Q1 2024 (March 31)1holders
$18.74avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Sage Therapeutics Inc. in their 13F filings. The largest holder was Byrne Asset Management LLC ($5K).
- Company
- Sage Therapeutics Inc.
- CUSIP
- 78667R100
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Byrne Asset Management LLC | 0.00% | Reduce -68.5% | 290 | $5K |
"% of holder's portfolio" is SAGE THERAPEUTICS INC's weight in each manager's 13F, not the share of Sage Therapeutics Inc. the manager owns.